Choriogonadotropin alfa biosimilar (Reliance Life Sciences)

绒促性素α生物类似药 (Reliance Life Sciences)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChoriogonadotropin alfa biosimilar (Reliance Life Sciences)
Drug Alias Name绒促性素α生物仿制药 (Reliance Life Sciences)rhCG - Reliance Life SciencesChorioRelR-TPR-020
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor agonistsOvarian follicle stimulants
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsInfertility
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesReliance Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesReliance Life Sciences
Inactive CompaniesN/A
Active IndicationsInfertility
Inactive IndicationsN/A

Other Information

ATC CodeG03GA08
Related LinksN/A